Quoin Pharmaceuticals, Ltd.
QNRX
$6.97
-$0.18-2.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -53.38% | -62.63% | -76.34% | -58.23% | -47.01% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -0.70% | -1.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.70% | -10.91% | -7.53% | 4.50% | 27.05% |
| Change in Net Operating Assets | 545.69% | -57.15% | 58,780.95% | 263.17% | 150.78% |
| Cash from Operations | -42.79% | -75.40% | -72.34% | -21.46% | -33.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -115.32% | -154.77% | -126.54% | -3.09% | 190.49% |
| Cash from Investing | -115.32% | -154.77% | -126.54% | -3.09% | 190.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 17.24% |
| Issuance of Common Stock | 198.62% | 197.96% | 60.92% | 13.61% | 13.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 219.70% | 218.96% | 64.25% | 16.05% | 19.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 285.03% | -135.08% | -84.06% | -2,653.32% | 38.53% |